title: [A case of pancreatic cancer treated by gemcitabine with sequential radiotherapy].
abstract: A 65-year-old man suffering from acute pancreatitis underwent MRI scanning, which revealed a low signal on the T1 and T2 sequences, and hypovascularity in arterial phase in the head of the pancreas. This corresponded to the area showing the absence of the lower common bile duct. FDG-PET was highly suggestive of pancreatic cancer (T4N1M0, Stage IVa) with lymph node metastasis. He was treated with systemic chemotherapy using gemcitabine (GEM) followed by radiotherapy. His symptoms gradually improved with a reduction in size of the primary lesion. The patient has been receiving systemic chemotherapy using S-1 without recurrence.
authors.affiliation: Department of Surgery, Health Insurance Hitoyoshi General Hospital.
authors.forename: Shoko
authors.initials: S
authors.lastname: Hisama
authors.forename: Masami
authors.initials: M
authors.lastname: Kimura
authors.forename: Takumasa
authors.initials: T
authors.lastname: Nishimura
authors.forename: Hiroo
authors.initials: H
authors.lastname: Matsushita
authors.forename: Shigeki
authors.initials: S
authors.lastname: Okamura
authors.forename: Seiya
authors.initials: S
authors.lastname: Saitoh
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Shimokawa
authors.forename: Akihiko
authors.initials: A
authors.lastname: Arakawa
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Toyama
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Tanaka
mesh_terms: D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004338:Drug Combinations; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009367:Neoplasm Staging; D010094:Oxonic Acid / Q000627:therapeutic use; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D012074:Remission Induction; D005641:Tegafur / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D004338:Drug Combinations; D003841:Deoxycytidine; C079198:S 1 (combination); D005641:Tegafur; D010094:Oxonic Acid; D000093542:Gemcitabine